Theratechnologies inc.

Theratechnologies inc.

October 24, 2007 15:03 ET

Media Advisory/Theratechnologies inc.-Lipodystrophy: A Little Known-Disease but a Ticking Time-Bomb for HIV Patients

Attend the Theratechnologies' symposium and late breaker to learn more about this disease and potential therapy

MONTREAL, QUEBEC--(Marketwire - Oct. 24, 2007) - Theratechnologies inc. (TSX:TH)

11th European AIDS Conference (EACS)
Madrid, Spain
When: Friday, October 26, 2007
Where: Palacio Municipal de Congresos
Campo de las Naciones
Avda. Capital de Espana, s/n
28042 Madrid

Antiretroviral therapy (ART) has dramatically improved the daily life, prognosis and survival of HIV-infected patients. However, patients living with HIV are at increased risk for other complications such as heart attacks and diabetes. HIV-associated lipodystrophy is characterized by metabolic abnormalities that may be associated with body composition changes and the noted increased risk of cardiovascular disease and diabetes.

Please join Theratechnologies for an educational symposium to learn more about HIV-associated lipodystrophy and therapeutic solutions being investigated.

First join us for:

Body Fat Changes and Metabolic Abnormalities in HIV: Facing the Challenge

Satellite Symposium

Friday, October 26

7:30 a.m. to 9:00 a.m.

Auditorium B

(i)Continental breakfast available starting at 7:00 a.m.

Learn about potential solutions when late-breaking long-term data is presented:

52-Week Phase III Results for Tesamorelin

Late-breaking data presentation

Friday, October 26

11 a.m.

Auditorium B

Study investigators, industry experts, and Theratechnologies representatives will be available for comment.

Contact Information